Tildrakizumab
Drug timelines are a Plus or Pro feature.
20 regulatory and trial events tracked for Tildrakizumab, covering 2018-06-27 to 2026-03-02. Get the full timeline:
Most recent: Clinical Trial Update: Observational Study of Tildrakizumab in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice